Summary

The North America wound care monitoring market is expected to reach USD 3.63 billion by 2031 from USD 2.42 billion in 2023, growing at a CAGR of 5.2% in the forecast period of 2024 to 2031.
Market Segmentation:
North America Wound Care Monitoring Market, By Product (Devices and Wound Assessment Apps), Modality (Wearable and Non-Wearable), Product Type (Contact Wound Measuring Devices and Non-Contact Wound Measuring Devices), Wound Type (Chronic Wounds and Acute Wounds), Application (Wound Healing Monitoring, Wound Assessment, Infection Detection, and Treatment Monitoring), End User (Hospitals, Clinics, Home Healthcare, Long-Term Care Facilities, Trauma Centers, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2031

Overview of North America Wound Care Monitoring Market Dynamics:
Driver
• Increasing prevalence of chronic diseases
Restraint
• High costs of advanced devices
Opportunity
• Increasing technological advancement in wound care

Market Players:
The key market players operating in the North America wound care monitoring market are listed below:
• Smith+Nephew
• Medline Industries, LP
• Mölnlycke Health Care AB
• Convatec Group PLC
• 3M
• The MolecuLight
• Spectral AI, Inc.
• Swift Medical Inc.
• eKARE, Inc.
• WoundVision
• WoundMatrix Mobile Wound Management
• Advanced Oxygen Therapy Inc.
• TISSUE ANALYTICS
• ThermoTek

ページTOPに戻る

Table of Contents

1 INTRODUCTION 44
1.1 OBJECTIVES OF THE STUDY 44
1.2 MARKET DEFINITION 44
1.3 OVERVIEW OF THE NORTH AMERICA WOUND CARE MONITORING MARKET 44
1.4 CURRENCY AND PRICING 46
1.5 LIMITATIONS 46
1.6 MARKETS COVERED 46
2 MARKET SEGMENTATION 49
2.1 MARKETS COVERED 49
2.2 GEOGRAPHICAL SCOPE 50
2.3 YEARS CONSIDERED FOR THE STUDY 51
2.4 DBMR TRIPOD DATA VALIDATION MODEL 52
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
2.6 MULTIVARIATE MODELLING 56
2.7 MARKET END USER COVERAGE GRID 57
2.8 PRODUCT LIFELINE CURVE 58
2.9 DBMR MARKET POSITION GRID 59
2.10 VENDOR SHARE ANALYSIS 60
2.11 SECONDARY SOURCES 61
2.12 ASSUMPTIONS 61
3 EXECUTIVE SUMMARY 62
4 PREMIUM INSIGHTS 67
4.1 PESTAL ANALYSIS 68
4.2 PORTERS FIVE FORCES 69
5 REGULATION COVERAGE 70
6 MARKET OVERVIEW 72
6.1 DRIVERS 74
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 74
6.1.2 INCREASING THE NUMBER OF PRODUCT LAUNCHES 76
6.1.3 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS 77
6.1.4 INCREASING GOVERNMENTAL SUPPORT AND THE R&D EXPENDITURE 78
6.2 RESTRAINTS 80
6.2.1 HIGH COSTS OF ADVANCED DEVICES 80
6.2.2 TECHNICAL CHALLENGES AND ACCURACY CONCERNS 80
6.2.3 CONSOLIDATION AMONG PAYERS AND BUYERS 81
6.3 OPPORTUNITIES 83
6.3.1 INCREASING TECHNOLOGICAL ADVANCEMENT IN WOUND CARE 83
6.3.2 INCREASING NUMBER OF PATIENTS UNDERGOING SURGICAL PROCEDURES 84
6.3.3 DIGITAL HEALTH INTERVENTIONS FOR CHRONIC WOUND MANAGEMENT 85
6.4 CHALLENGES 86
6.4.1 LACK OF SKILLED LABOR FORCE 86
6.4.2 COMPLEXITY INVOLVED IN THE USAGE OF THE DEVICES 86
7 NORTH AMERICA WOUND CARE MONITORING MARKET, BY PRODUCT 88
7.1 OVERVIEW 89
7.2 DEVICES 92
7.2.1 WOUND MEASUREMENT DEVICES 93
7.2.2 WOUND DRESSINGS WITH INTEGRATED SENSORS 93
7.2.3 SMART BANDAGES 93
7.2.4 WOUND INFECTION DETECTION SENSORS 93
7.2.5 PH MONITORING DEVICES 93
7.2.6 WOUND IMAGING SYSTEMS 93
7.2.6.1 DIGITAL IMAGING 93
7.2.6.2 FLUORESCENCE IMAGING 93
7.2.6.3 INFRARED THERMOGRAPHY 93
7.2.6.4 OPTICAL COHERENCE TOMOGRAPHY (OCT) 93
7.2.6.5 OTHERS 93
7.2.7 MOISTURE MANAGEMENT SYSTEMS 93
7.2.8 PRESSURE ULCER MONITORING DEVICES 93
7.2.9 DIGITAL WOUND DOCUMENTATION SYSTEMS 93
7.2.10 OTHERS 93
7.3 WOUND ASSESSMENT APPS 94
8 NORTH AMERICA WOUND CARE MONITORING MARKET, BY PRODUCT TYPE 95
8.1 OVERVIEW 96
8.2 CONTACT WOUND MEASURING DEVICES 99
8.3 NON-CONTACT WOUND MEASURING DEVICES 99
9 NORTH AMERICA WOUND CARE MONITORING MARKET, BY MODALITY 100
9.1 OVERVIEW 101
9.2 WEARABLE 104
9.3 NON-WEARABLE 104
9.3.1 STANDALONE 105
9.3.2 PORTABLE 105
10 NORTH AMERICA WOUND CARE MONITORING MARKET, BY WOUND TYPE 106
10.1 OVERVIEW 107
10.2 CHRONIC WOUNDS 110
10.2.1 DIABETIC FOOT ULCERS 110
10.2.2 PRESSURE ULCERS 110
10.2.3 VENOUS LEG ULCERS 110
10.2.4 ARTERIAL ULCERS 110
10.3 ACUTE WOUNDS 111
10.3.1 SURGICAL WOUNDS 111
10.3.2 TRAUMATIC WOUNDS 111
10.3.3 BURN WOUNDS 111
11 NORTH AMERICA WOUND CARE MONITORING MARKET, BY APPLICATION 112
11.1 OVERVIEW 113
11.2 WOUND HEALING MONITORING 116
11.3 WOUND ASSESSMENT 116
11.3.1 SIZE MEASUREMENT 117
11.3.2 DEPTH MEASUREMENT 117
11.3.3 TISSUE TYPE ASSESSMENT 117
11.4 INFECTION DETECTION 117
11.5 TREATMENT MONITORING 118
12 NORTH AMERICA WOUND CARE MONITORING MARKET, BY DISTRIBUTION CHANNEL 119
12.1 OVERVIEW 120
12.2 DIRECT TENDERS 123
12.3 RETAIL SALES 123
12.3.1 OFFLINE 124
12.3.2 ONLINE 124
13 NORTH AMERICA WOUND CARE MONITORING MARKET, BY END USER 125
13.1 OVERVIEW 126
13.2 HOSPITALS 129
13.2.1 INPATIENT 129
13.2.2 OUTPATIENT 129
13.3 CLINICS 130
13.3.1 WOUND CARE CLINICS 130
13.3.2 DERMATOLOGY CLINICS 130
13.4 HOME HEALTHCARE 131
13.5 LONG-TERM CARE FACILITIES 131
13.6 TRAUMA CENTERS 132
13.7 OTHERS 132
14 NORTH AMERICA WOUND CARE MONITORING MARKET, BY REGION 133
14.1 NORTH AMERICA 135
14.1.1 U.S. 140
14.1.2 CANADA 144
14.1.3 MEXICO 148
15 NORTH AMERICA WOUND CARE MONITORING MARKET: COMPANY LANDSCAPE 152
15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS 153
17 COMPANY PROFILE 154
17.1 SMITH+NEPHEW 154
17.1.1 COMPANY SNAPSHOT 154
17.1.2 REVENUE ANALYSIS 154
17.1.3 COMPANY SHARE ANALYSIS 155
17.1.4 PRODUCT PORTFOLIO 155
17.1.5 RECENT DEVELOPMENT 156
17.2 MEDLINE INDUSTRIES, LP 157
17.2.1 COMPANY SNAPSHOT 157
17.2.2 COMPANY SHARE ANALYSIS 157
17.2.3 PRODUCT PORTFOLIO 158
17.2.4 RECENT DEVELOPMENTS 158
17.3 MÖLNLYCKE HEALTH CARE AB 160
17.3.1 COMPANY SNAPSHOT 160
17.3.2 COMPANY SHARE ANALYSIS 160
17.3.3 PRODUCT PORTFOLIO 161
17.3.4 RECENT DEVELOPMENT 161
17.4 CONVATEC GROUP PLC 162
17.4.1 COMPANY SNAPSHOT 162
17.4.2 REVENUE ANALYSIS 162
17.4.3 COMPANY SHARE ANALYSIS 163
17.4.4 PRODUCT PORTFOLIO 163
17.4.5 RECENT DEVELOPMENTS 163
17.5 3M 165
17.5.1 COMPANY SNAPSHOT 165
17.5.2 REVENUE ANALYSIS 165
17.5.3 PRODUCT PORTFOLIO 166
17.5.4 RECENT DEVELOPMENT 167
17.6 ADVANCED OXYGEN THERAPY INC. 168
17.6.1 COMPANY SNAPSHOT 168
17.6.2 1.1.4 REVENUE ANALYSIS 168
17.6.3 SOLUTION PORTFOLIO 169
17.6.4 RECENT DEVELOPMENT 169
17.7 DIGITALMEDLAB LTD. 170
17.7.1 COMPANY SNAPSHOT 170
17.7.2 PRODUCT PORTFOLIO 170
17.7.3 RECENT DEVELOPMENT 170
17.8 EKARE, INC. 171
17.8.1 COMPANY SNAPSHOT 171
17.8.2 PRODUCT PORTFOLIO 171
17.8.3 RECENT DEVELOPMENT 171
17.9 IMITO AG 172
17.9.1 COMPANY SNAPSHOT 172
17.9.2 PRODUCT PORTFOLIO 172
17.9.3 RECENT DEVELOPMENT 172
17.10 SPECTRAL AI, INC. 173
17.10.1 COMPANY SNAPSHOT 173
17.10.2 REVENUE ANALYSIS 173
17.10.3 PRODUCT PORTFOLIO 174
17.10.4 RECENT DEVELOPMENT 174
17.11 SWIFT MEDICAL INC. 175
17.11.1 COMPANY SNAPSHOT 175
17.11.2 SOLUTION PORTFOLIO 175
17.11.3 RECENT DEVELOPMENT 175
17.12 THE MOLECULIGHT 176
17.12.1 COMPANY SNAPSHOT 176
17.12.2 SOLUTION PORTFOLIO 176
17.12.3 RECENT DEVELOPMENT 177
17.13 TISSUE ANALYTICS 178
17.13.1 COMPANY SNAPSHOT 178
17.13.2 PRODUCT PORTFOLIO 178
17.13.3 RECENT DEVELOPMENT 178
17.14 THERMOTEK 179
17.14.1 COMPANY SNAPSHOT 179
17.14.2 PRODUCT PORTFOLIO 179
17.14.3 RECENT DEVELOPMENT 179
17.15 WOUNDMATRIX MOBILE WOUND MANAGEMENT 180
17.15.1 COMPANY SNAPSHOT 180
17.15.2 SERVICE PORTFOLIO 180
17.15.3 RECENT DEVELOPMENT 180
17.16 WOUNDVISION 181
17.16.1 COMPANY SNAPSHOT 181
17.16.2 SOLUTION PORTFOLIO 181
17.16.3 RECENT DEVELOPMENT 181
18 QUESTIONNAIRE 182
19 RELATED REPORTS 185